The most recent Success stories from EU Research. Select a theme or country from the menus on the left to see more articles
Tick (check) box to add article to PDF "basket"
An EU- and industry-funded project has identified potential biomarkers that could indicate how likely a drug is to cause cancer at an earlier stage of testing than is currently possible, which could save drug companies time and money - and lead to safer drugs reaching patients faster.
Published: 8 June 2018
The incidence of cancer in Europe is increasing but many potential new drug treatments are found to be ineffective when tested on patients. An EU and industry-funded project has investigated new models of tumours to help researchers discover more effective treatments and boost survival rates.
Published: 27 November 2017
EU-funded researchers have developed an efficient colorectal cancer treatment that can prevent relapses in patients post-surgery. It involves applying drugs that kill cancer cells directly to the tumour site, eliminating the need for unpleasant, ongoing injections that can cause side effects.
Published: 14 November 2017
There is still a lot to learn about the genetic changes that occur as melanoma tumours form - and about the body's response to this illness. Greater understanding could help to predict how individual tumours are likely to respond to various combinations of therapies. An EU-funded network is training young researchers who are exploring this issue.
Published: 10 November 2017
A Marie Skłodowska-Curie fellowship grant has enabled an ambitious young French researcher to make important advances in identifying a possible genetic association between endometriosis (when tissue that normally grows inside the uterus grows outside) and a higher risk of developing melanoma, a skin cancer.
Published: 8 November 2017
October marks Breast Cancer Awareness Month, highlighting the plight of patients and efforts to fight this potentially deadly disease that claims around 570 000 lives a year around the world. The EU is doing its part by funding a range of promising research projects, including two that are developing tools to better determine a womans breast cancer risk in order to optimise screening and prevention - and ultimately save lives.
Published: 23 October 2017
EU-industry funded researchers have worked to identify and characterise signs of cancer, particularly colon cancers, and patients' responses to different types of treatment. The aim is to help doctors choose the best possible treatment for an individual patient's condition, potentially improving and saving lives.
Published: 21 September 2017
A novel approach to analysing DNA for signs of mutation and disease is leading to highly accurate tests for early-stage cancer, antibiotic resistance and genetic disorders, potentially revolutionising diagnostic medicine and saving lives.
Published: 17 August 2017
European researchers have identified a novel approach to prevent the growth of cancer tumours and inhibit them from spreading, potentially leading to highly effective treatments with fewer side effects.
Published: 7 March 2017
Every cancer follows its own complex path. An EU-funded project is developing experimental tools and a computer model to generate and test ideas on the combined impact of the body's cell and chemical processes on cancer progress. The findings should one day help researchers and SMEs find better-targeted drugs faster.
Published: 6 February 2017